NephroGenex Inc (NASDAQ:NRX)

7.46
Delayed Data
As of 12:17pm ET
 -0.01 / -0.13%
Today’s Change
3.96
Today|||52-Week Range
17.98
-44.12%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close7.47
Today’s open7.51
Day’s range7.09 - 7.65
Volume11,360
Average volume (3 months)48,669
Market cap$66.2M
Dividend yield--
Data as of 12:17pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)-2.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
CBAYCymaBay Therapeutics...-0.11-2.73%
DITAMCON Distributing C...+0.32+0.38%
MCPIEMed Cannabis Pharma ...0.000.00%
BIOSBioScrip Inc-0.12-3.17%
Data as of 12:53pm ET, 05/26/2015

Financials

Last reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pierre Legault
President &
Chief Scientific Officer
J. Wesley Fox Ahmann
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers